Logo 1 Logo 2

Clinical Trial Details

Trial ID: L0549
Source ID: NCT00160121
Associated Drug: Lanthanum Carbonate
Title: Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal Disease
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Kidney Failure, Chronic
Interventions: DRUG: Lanthanum carbonate
Outcome Measures: Primary: Pre-dialysis serum phosphorus levels at 12 weeks, Week 12|Patient satisfaction questionnaire at 12 weeks, 7 question patient satisfaction questionnaire for participants to respond to how strongly they agree or disagree with their experience with the medication received in this clinical trial. Question are based on a 4 point ordinal scale of: Strongly Agree, Agree, Disagree, Strongly Disagree., Week 12|Physician satisfaction questionnaire at 12 weeks, 6 question physician satisfaction questionnaire for physicians to respond to how strongly they agree or disagree with their patient's experience with the medication received in this clinical trial. Question are based on a 4 point ordinal scale of: Strongly Agree, Agree, Disagree, Strongly Disagree., Week 12|Patient preference questionnaire at 12 weeks, 6 question patient preference questionnaire for participants to respond to whether they preferred the medication they received during this clinical trial or their previous medication., Week 12|Physician preference questionnaire at 12 weeks, 7 question physician preference questionnaire for physicians to respond to whether they preferred the medication administered during this clinical trial or their patient's previous medication., Week 12 |
Sponsor/Collaborators: Sponsor: Shire
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 2500
Study Type: INTERVENTIONAL
Study Designs: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2005-01-10
Completion Date: 2005-12-13
Results First Posted:
Last Update Posted: 2021-07-02
Locations:
URL: https://clinicaltrials.gov/show/NCT00160121